Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.78 |
| ▸ | MEN1 | O00255 | 2/20 | 0.78 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.78 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.78 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.78 |
| ▸ | CRHBP | P24387 | 1/20 | 0.78 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.78 |
| ▸ | TRPM8 | Q7Z2W7 | 5/20 | 0.57 |
| ▸ | CDC7 | O00311 | 9/20 | 0.56 |
| ▸ | DBF4 | Q9UBU7 | 9/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | DHODH | Q02127 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20642209 | 0.89 | MAPT (0.68) | MAPTMEN1KMT2AKDM4EHSP90AA1 | |
| SCHEMBL2886858 | 0.89 | MAPT (0.80) | MAPTMEN1KMT2AKDM4EHSP90AA1 | |
| SCHEMBL8341363 | 0.88 | MAPT (0.78) | MAPTMEN1KMT2AKDM4EHSP90AA1 | |
| SCHEMBL4471162 | 0.86 | MAPT (0.76) | MAPTMEN1KMT2AKDM4EHSP90AA1 | |
| SCHEMBL4804421 | 0.86 | MAPT (0.76) | MAPTMEN1KMT2AKDM4EHSP90AA1 | |
| SCHEMBL4484447 | 0.86 | MAPT (0.76) | MAPTMEN1KMT2AKDM4EHSP90AA1 | |
| SCHEMBL4467429 | 0.85 | MAPT (0.74) | MAPTMEN1KMT2AKDM4EHSP90AA1 | |
| SCHEMBL4809764 | 0.85 | MAPT (0.74) | MAPTMEN1KMT2AKDM4EHSP90AA1 | |
| SCHEMBL14394668 | 0.84 | MAPT (0.73) | MAPTMEN1KMT2AKDM4EHSP90AA1 | |
| SCHEMBL4468293 | 0.84 | MAPT (0.73) | MAPTMEN1KMT2AKDM4EHSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7449468-B2 | Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors | SMITHKLINE BEECHAM CORPORATION (US) | 2008-11-11 | — | — | US | disclosed |
| US-20070225294-A1 | THIAZOLE AND OXAZOLE DERIVATIVES AS ACTIVATORS OF HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS | BANKER PIERETTE | 2007-09-27 | — | — | US | disclosed |
| US-7229998-B2 | Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors | SMITHKLINE BEECHAM CORPORATION (US) | 2007-06-12 | — | — | US | disclosed |
| US-20070072871-A1 | THIAZOLE AND OXAZOLE DERIVATIVES AS ACTIVATORS OF HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS | BANKER PIERETTE | 2007-03-29 | — | — | US | disclosed |
| US-20060052603-A1 | Process for preparing substituted phenoxy-acetic acids from phenols | SMITHLKINE BEECHAM CORPORATION | 2006-03-09 | — | — | US | disclosed |
| EP-1546124-A1 | PROCESS FOR PREPARING SUBSTITUTED PHENOXY-ACETIC ACIDS FROM PHENOLS | SmithKline Beecham Corporation (US) | 2005-06-29 | — | — | EP | disclosed |
| EP-1349843-B1 | THIAZOLE AND OXAZOLE DERIVATIVES AS ACTIVATORS OF HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS | SMITHKLINE BEECHAM CORP (US) | 2005-04-20 | — | — | EP | disclosed |
| US-20040072838-A1 | Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors | SMITHKLINE BEECHAM CORPORATION | 2004-04-15 | — | — | US | disclosed |
| WO-2004026849-A1 | PROCESS FOR PREPARING SUBSTITUTED PHENOXY-ACETIC ACIDS FROM PHENOLS | SMITHKLINE BEECHAM CORPORATION (US) | 2004-04-01 | — | — | WO | disclosed |
| EP-1349843-A1 | THIAZOLE AND OXAZOLE DERIVATIVES AS ACTIVATORS OF HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS | GLAXO GROUP LIMITED (GB) | 2003-10-08 | — | — | EP | disclosed |
| WO-2002059098-A1 | THIAZOLE AND OXAZOLE DERIVATIVES AS ACTIVATORS OF HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS | GLAXO GROUP LIMITED (GB) | 2002-08-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070072871-A1 | THIAZOLE AND OXAZOLE DERIVATIVES AS ACTIVATORS OF HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS | PPARD, PPARG, PPARA | MAPT 4713/4885MEN1 4766/4885KMT2A 4234/4885 |
| US-20070225294-A1 | THIAZOLE AND OXAZOLE DERIVATIVES AS ACTIVATORS OF HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS | GPR119, PPARA, PPARG | MAPT 4805/4885MEN1 4456/4885KMT2A 3815/4885 |
| US-20060052603-A1 | Process for preparing substituted phenoxy-acetic acids from phenols | HPD, PAH, GNPAT | MAPT 1622/4885MEN1 3601/4885KMT2A 1098/4885 |
| US-20040072838-A1 | Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors | PPARA, PPARG, PPARD | MAPT 4132/4885MEN1 4401/4885KMT2A 3950/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.